Indian Pharmaceutical Market
-
Torrent Pharma Seals Deal for Controlling Stake in J. B. Chemicals from KKR
Torrent Pharmaceuticals is set to acquire a controlling stake in JB Pharma from KKR for INR 25,689 crores. This strategic move, followed by a merger, aims to significantly expand Torrent’s presence in the Indian pharmaceutical market. It will bolster their chronic segment expertise, introduce international CDMO capabilities, and enhance market share and operational synergies. The deal also diversifies Torrent’s business into the promising CDMO sector.
